Search

everythinglearnresearchcommunity

for

Search:↓

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Spironolactone reduces hair growth in women with unexplained excessive hairiness.

New treatments for excessive hair growth in women, including advanced drugs and nanotechnology, show promise for better results.

Hormone therapy can improve sexual health and quality of life for women 70 and older.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

Thyroid receptor agonists may treat male pattern baldness without harmful side effects.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

Antiandrogen therapy is effective and well tolerated for treating women's androgenic disorders like hirsutism, acne, and hair loss.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

Men with low testosterone or breast growth should be checked for Cushing syndrome.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Flutamide effectively reduces hair growth in women with hirsutism and improves acne and seborrhea without side effects.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Alopecia patients have higher heart disease risk; statins and finasteride may help.

Spironolactone is effective in treating excessive hair growth in women.

β-estradiol slows hair growth in mice.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.